Intero Biosystems wants drugmakers to test on mini human intestines, not animals | TechCrunch
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Next post
McKinsey is making job applicants spar with a fake AI client
Related posts
Is Jensen Huang’s job on the line? Yale’s Jeffrey Sonnenfeld estimates it’s “about a 50-50” | TechCrunch
techcrunch.com
Flock, maker of controversial license plate readers, starts to give campaign cash to local politicians
reddit.com
A Truck Demanding EA ‘Save Mass Effect’ Is Currently Driving Around The Company’s Headquarters
reddit.com
